Ratnakar Securities Pvt. Ltd.

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal

BSE2964.30-61.65 (-2.04 %)

PREV CLOSE ( ) 3025.95

OPEN PRICE ( ) 3024.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 18956

TODAY'S LOW / HIGH ( )2934.60 3037.80

52 WK LOW / HIGH ( )2295.1 3542.6

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 14-02 1995

Management Info

Arvind Lal - Chairman - Managing Director

Registered Office

Address Block E,Sector 18,Rohini,
New Delhi,
Delhi-110085

Phone 011-30258600

Email lalpathlabs@lalpathlabs.com

Website www.lalpathlabs.com

Registrars Details

MUFG Intime India Pvt Ltd.

Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi

Listing : BSE, NSE

NEWS

26Nov Lal PathLabs informs about press release
Pursuant to Regulation 30 of the Listing Regulations, Lal PathLabs has i..

26Nov Dr. Lal PathLabs launches Indiaâ€™s fi
Dr. Lal PathLabs (DLPL) has launched Indiaâ€™s first dedicated Complemen..

01Nov Dr. Lal PathLabs informs about receipt
Pursuant to the provisions of Regulation 30 read with Schedule III of th..

01Nov Dr. Lal PathLabs informs about press r
Dr. Lal PathLabs has informed that it attached the copy of newspaper adv..

24Sep Dr. Lal Pathlabs gets nod to acquire p
Dr. Lal Pathlabs has received approval from its Board to acquire immovab..

Financials

in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	1457	4973
Gross Profit	1948	6213
Operating Profit	2379	7770
Net Sales	6996	23516

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Thyrocare Tech. (BSE) 421.85 (2.71%)	M.Cap ( in Cr)6691.16
Narayana Hrudayalay (BSE) 1923.25 (0.35%)	M.Cap ( in Cr)39303.69
Global Longlife Hosp (BSE) 17.10 (9.34%)	M.Cap ( in Cr)17.96
KK Shah Hospitals (BSE) 40.50 (1.25%)	M.Cap ( in Cr)27.57
Artemis Medicare (BSE) 270.20 (0.11%)	M.Cap ( in Cr)4249.27

Shareholding Pattern

	NON-INSTITUTION	6.58%
	PROMOTERS	53.21%
	FI/BANKS/INSURANCE	2.11%
	MUTUAL FUNDS/UTI	15.9%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
NJ ELSS Tax Saver S...	4.66
Shriram Multi Secto...	3.47
Bajaj Finserv Healt...	3.24
Tata India Pharma &...	2.94
PGIM India Healthca...	2.81
DSP Nifty Smallcap2...	2.57

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

DR. LAL PATHLABS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES